Pindolol

CAS No. 13523-86-9

Pindolol( DL-Pindolol )

Catalog No. M11429 CAS No. 13523-86-9

Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pindolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).
  • Description
    Pindolol is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial agonist / antagonist (Ki=33nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DL-Pindolol
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1A| β-adrenergic receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    13523-86-9
  • Formula Weight
    248.32
  • Molecular Formula
    C14H20N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
  • Chemical Name
    1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Joseph SS, et al. Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):496-503.
molnova catalog
related products
  • Mosapride Citrate

    Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

  • idalopirdine

    Idalopirdine a selective 5-HT6 receptor antagonist(?Ki : 0.83 nM)as a treatment for Alzheimer's disease.

  • SEP-363856 hydrochlo...

    SEP-363856 hydrochloride is an agent of orally active and CNS active psychotropic with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects, has the potential to treatment of schizophrenia. SEP-856 (10μM) specifically inhibits α2A, α2B, D2, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7> 50% receptor.